Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
North Carolina
*Industry: Research Triangle, North Carolina
*Bioscience Regional Clusters & HotSpots
*Industry: Northern California & Silicon Valley

Kintsugi

Attachments

*Architects: Telemedicine (TelePsychiatry, TeleMental Health, TeleBehavioral Health, Digital Mental / Behavioral Health Companies)
*Contractors & Awardees: NSF
*Industry: Northern California & Silicon Valley
Fierce Healthcare's Fierce 15 of 2023
Venture Capital: Series A

2022: Kintsugi Raises $20M Series A from Insight Partners, Works Towards New Standard for Mental Healthcare
2022: Series A funding round was led by New York-based global venture capital and private equity firm Insight Partners, with participation from Acrew Capital, Darling Ventures, Citta Capital, Side Door Ventures, Primetime Partners, IT Farm, AngelList Fund, and Alpha Edison
Awarded multiple distinctions for novel AI technology through the National Science Foundation, Kintsugi detects signs of clinical depression and anxiety from short clips of free-form speech, closing mental health care gaps across risk-bearing health systems, saving time and lives.
Berkeley, California
Developing novel voice biomarker infrastructure to detect signs of depression and anxiety from short clips of free form speech.
Grace Chang, Founder/CEO of Kintsugi (2022)
Integrated into the world’s most innovative enterprise call centers, telehealth platforms, and remote patient monitoring apps
KiVA™ - Kintsugi Voice Biomarker API
Voice biomarker-based mental health